Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
Role of Cerebellum and Prefrontal Cortex in Memory01:14

Role of Cerebellum and Prefrontal Cortex in Memory

The cerebellum, while traditionally associated with motor control, also plays a crucial role in memory, particularly in procedural memory, which involves learning motor tasks that become automatic through repetition. For example, studies have shown that when the cerebellum is damaged, individuals or animals lose the ability to learn conditioned motor responses, such as the conditioned eye-blink response in classical conditioning experiments with rabbits. This study demonstrates the cerebellum's...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Extreme plate boundary localization promotes shallow earthquake slip at the Japan Trench.

Science (New York, N.Y.)·2025
Same author

Information-based TMS to mid-lateral prefrontal cortex disrupts action goals during emotional processing.

Nature communications·2024
Same author

Perspectives of Interstitial Lung Disease Patients and Carers During COVID-19.

Irish medical journal·2021
Same author

Rates, costs, return to work and reoperation following spinal surgery in a workers' compensation cohort in New South Wales, 2010-2018: a cohort study using administrative data.

BMC health services research·2021
Same author

Imaging post liver transplantation part II: biliary complications.

Clinical radiology·2020
Same author

Imaging post liver transplantation part I: vascular complications.

Clinical radiology·2020

Related Experiment Video

Updated: Jun 17, 2026

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
07:26

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

Enhanced frontal function in Parkinson's disease.

R Cools1, A Miyakawa, M Sheridan

  • 1Donders Institute for Brain, Cognition and Behaviour, Centre for Cognitive Neuroimaging, Radboud University Nijmegen Medical Centre, Department of Psychiatry, The Netherlands. roshan.cools@donders.ru.nl

Brain : a Journal of Neurology
|December 10, 2009
PubMed
Summary
This summary is machine-generated.

Parkinson's disease patients showed improved distraction resistance but worse working memory when off dopamine medication. Dopamine therapy normalized these cognitive functions, suggesting a balance in brain dopamine levels is key.

More Related Videos

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

Related Experiment Videos

Last Updated: Jun 17, 2026

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
07:26

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

Area of Science:

  • Neuroscience
  • Cognitive Psychology
  • Neurology

Background:

  • Dopamine plays a crucial role in cognitive functions, including working memory.
  • Parkinson's disease is characterized by dopamine deficiency, particularly in the striatum.
  • The impact of dopamine levels on specific working memory components remains under investigation.

Purpose of the Study:

  • To investigate the role of dopamine in working memory.
  • To examine how dopaminergic medication withdrawal affects cognitive performance in Parkinson's disease patients.
  • To explore the relationship between dopamine levels and distractibility versus memory span.

Main Methods:

  • Assessed working memory performance in Parkinson's disease patients OFF and ON dopaminergic medication, compared to controls.
  • Utilized a delayed response task to measure resistance to distraction.
  • Employed a backward digit span test to evaluate working memory capacity.

Main Results:

  • Parkinson's disease patients OFF medication exhibited enhanced resistance to distraction but impaired backward digit span performance.
  • Dopaminergic medication normalized both distractibility and backward digit span performance.
  • Performance of patients ON medication did not differ from controls.

Conclusions:

  • Altered dopamine levels in Parkinson's disease significantly impact working memory components.
  • Hypothesize that low striatal and potentially upregulated frontal dopamine contribute to observed cognitive changes.
  • Dopaminergic medication may restore cognitive function by rebalancing dopamine transmission between the striatum and prefrontal cortex.